Created at	Source	Raw Value	Validated value
Oct. 28, 2022, noon	usa	Number of participants with Treatment Emergent Adverse Event (TEAEs) in multiple ascending doses;PK parameters for ASC10, GLC01-700 (molnupiravir) and ASC10-A in plasma as AUC0-12h	Number of participants with Treatment Emergent Adverse Event (TEAEs) in multiple ascending doses;PK parameters for ASC10, GLC01-700 (molnupiravir) and ASC10-A in plasma as AUC0-12h